tirzepatide info Looking to lose weight and improve your health? Look no further than Tirzepatide! Our latest post has all the information you need to know about this breakthrough weight loss medication. With We PDB-101: Diabetes Mellitus: Diabetes Mellitus:

Patients should discuss with their primary care physician and/or endocrinologist whether they should cease GLP-1 medication use in order to balance the risk of vision loss from NAION in the fellow eye with the hypoglycemic and cardiovascular benefits from treatment

The US Type 1 Diabetes Exchange Clinic Network reported that 4.8% of participants (age 26 to 93 years) had been hospitalised for DKA in the prior year [41]

Its ability to reduce hepatic fat and visceral adipose tissue further underscores its potential advantage in treating MASH over GLP-1 RAs [40]

PMID 31490017

In an in vitro study by Zhao et al., liraglutide reduced cell proliferation and increased cell apoptosis in estrogen receptor-positive breast cancer cells (Zhao et al., 2018)